Artificial intelligence could have profound implications for the field of oncology, concluded panelists speaking to journalist and moderator Katie Couric at the Constellation Forum 2023 at Northwell Health last week.
Dr. Richard Barakat, physician in chief and executive director of cancer services and research division at Northwell Health, noted that using AI in imaging will help radiologists and...
Cancer detection technology startup Adela announced it secured $48 million in funding, bringing its total raise to $108 million.
Labcorp joined the round as a new investor alongside existing investors OrbiMed, Decheng Capital, F-Prime Capital, Deerfield Management and RA Capital Management.
Adela also named Lisa Alderson as its interim CEO. Alderson has served on the company's board of...
Employer-focused cancer startup AccessHope announced it is adding Johns Hopkins Medicine's Sidney Kimmel Comprehensive Cancer Care Center to its network of National Cancer Institute-designated organizational partners.
AccessHope connects employers offering self-funded health plans and employees' treating physicians with cancer-focused expertise from NCI-Designated Comprehensive Cancer Centers...
Digital oncology platform Jasper Health is partnering with employer-focused third-party administration platform Covet Health to offer its cancer care support services to Covet's members.
Jasper Health provides a hybrid digital, but human-led, cancer care platform for patients and providers that offers care navigation and guidance, data insights, remote patient monitoring capabilities, cancer...
Multinational pharmaceutical and biotech company Pfizer and AI-powered data company Tempus announced a multiyear strategic alliance to utilize AI and machine learning to inform drug discovery and development in oncology.
Pfizer will leverage Tempus' library of de-identified data to accelerate therapeutic development in oncology. It will also use Tempus' AI-driven companion diagnostic offerings...
Oncology patients saved both time and travel costs when utilizing telehealth services, reducing the cost burden associated with cancer care, according to a study published in JAMA Network Open.
The economic evaluation, conducted through Moffitt Cancer Center, estimated patient cost savings due to telehealth, including the cost of travel and potential loss of productivity due to the medical visit...
Medical AI startup Qritive has pooled $7.5 million in a funding round led by MassMutual Ventures and supported by Enterprise Singapore's investment arm SEEDS Capital and Exfinity Venture Partners.
WHAT IT DOES
Founded in 2017, the Singapore-headquartered company offers diagnostic support solutions that provide fast and accurate pathological interpretations "within seconds." Its digital pathology...
Roche, one of the largest pharma companies in Europe, has been expanding its ambitions in genomic and personalized medicine, emerging practices that use information about a patient's genetic profile or proteins to prevent, diagnose or treat disease.
Dr. Oliver Bleck, area head of Europe South at Roche, joined MobiHealthNews to discuss Roche's advancements in oncology, its current work in...
Australian researchers have developed an online tool to help cancer survivors manage their fears of cancer recurrence.
A research team has made a digital adaptation of a therapist-delivered treatment called ConquerFear, which was originally developed by the Psycho-Oncology Co-operative Research Group, a national cancer clinical trial group under the University of Sydney. The treatment has been...
Researchers from the Indian Institute of Technology in Madras have come up with a new AI prediction tool that can detect cancer-causing genes in individuals.
WHAT IT DOES
Dubbed PIVOT, the AI tool is based on a prediction model that uses information on mutations, expression of genes, and copy number variation in genes and perturbations in the biological network due to an altered gene expression....